Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in ThailandBusiness Wire • 05/31/21
Illumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 05/27/21
Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product DevelopmentBusiness Wire • 05/17/21
Illumina Files Action for Annulment of European Commission's Decision Asserting Jurisdiction to Review GRAIL AcquisitionBusiness Wire • 04/29/21
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics InitiativeBusiness Wire • 04/28/21
Illumina, Inc. (ILMN) CEO Francis deSouza on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/28/21
Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer IndicationsBenzinga • 04/23/21
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion DiagnosticBusiness Wire • 04/22/21
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood TestBusiness Wire • 04/20/21